Uni-Bio Science Group Ltd 2021 SR
The report details Uni-Bio Science Group Ltd.'s sustainability performance for the 2021 fiscal year, highlighting a period of structural streamlining and improved operational efficiency. Key developments include the launch of 'Acarbose' for diabetes treatment and a HK$50.2 million investment in research and development. The company achieved ISO 14001 and ISO 50001 certifications, reinforcing its commitment to environmental and energy management. A materiality assessment identified 14 high-priority ESG issues, such as drug quality and occupational health. The Group reported zero workplace fatalities and implemented measures to reduce noise and enhance safety at its production facilities.
Company: Uni-Bio Science Group Ltd
Sector: Manufacturing
Country: Hong Kong
Year: 2021
Type: SR
Pages: 34
Uni-Bio Science Group Ltd
The report details Uni-Bio Science Group Ltd.'s sustainability performance for the 2021 fiscal year, highlighting a period of structural streamlining and improved operational efficiency. Key developments include the launch of 'Acarbose' for diabetes treatment and a HK$50.2 million investment in research and development. The company achieved ISO 14001 and ISO 50001 certifications, reinforcing its commitment to environmental and energy management. A materiality assessment identified 14 high-priority ESG issues, such as drug quality and occupational health. The Group reported zero workplace fatalities and implemented measures to reduce noise and enhance safety at its production facilities.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Workplace Fatalities
Employees